Study hospitals
| Site* | Absolute change in β blocker use at discharge (% points) | Rate of β blocker use at discharge | ||
|---|---|---|---|---|
| Follow up (% of patients) | Baseline | Staffed beds | ||
| *Listed by state abbreviation. | ||||
| H7. CA | +30 | 73 | 43 | 271 |
| H8. OH | +22 | 69 | 47 | 428 |
| H4. FL | +12 | 68 | 56 | 629 |
| H3. CA | +7 | 46 | 39 | 263 |
| H1. NY | +6 | 67 | 61 | 231 |
| H6. AR | +6 | 35 | 29 | 275 |
| H5. MO | −16 | 47 | 63 | 708 |
| H2. MN | −21 | 45 | 66 | 110 |